BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease

NCT04229927 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

712

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Alzheimer's Disease

Interventions

DRUG: BPDO-1603

Sponsor

Hyundai Pharmaceutical Co., LTD.